Clinical trial design is a key aspect of the successful conduct of clinical trials. It involves deciding parameters such as the number of patients, the length of the trial, the comparator arm (in ...

Cambridge, Massachusetts Monday, January 13, 2025, 15:00 Hrs [IST] ...

IGC Pharma (IGC) announced that its ongoing Phase 2 trial for agitation in Alzheimer’s disease has been officially named CALMA. The trial’s new ...